Cure Pharmaceutical
Oxnard, US
Biotech
Founders & leadership
WN
Wayne NasbyDirector
RD
Rob DavidsonChief Executive Officer
IS
Ian SephtonDirector
VB
Vic BranstetterDirector
MU
Mark UdellChief Financial Officer
EM
Ed MaliskiDirector
Reported raises · per SEC filings
Form D private placements$6MraisedOct 2016 · 42 investors · Pharmaceuticals
Rule 506(b)$323.2KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)$2MraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)$250KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)$80KraisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.